Healthcare Signals That Matter
Everything that happens in the healthcare space is a signal to healthcare marketers.
The CDC Is Investing $107 Million in Ebola Preparedness
A closer look at the CDC’s $107 million Ebola preparedness investment and what it signals for outbreak readiness, public health infrastructure, and healthcare response planning.
Why Everyone Is Betting on GLP-1 Drugs
Watch the full breakdown of why GLP-1 drugs have become one of healthcare’s most important market, investment, and commercial signals.
Billions Are Pouring Into Cancer and Alzheimer's Research
Explore the major investments, partnerships, and scientific advances directing billions of dollars toward new cancer and Alzheimer’s treatments.
Big Pharma Is Doubling Down on Gene Therapy
See why major pharmaceutical companies are increasing their commitment to gene therapy through new research programs, partnerships, approvals, and acquisitions.
Gene Therapy Is Attracting Billion-Dollar Deals
Discover how gene therapy is driving billion-dollar licensing agreements, acquisitions, and strategic investments across the pharmaceutical industry.
AI Is Moving Deeper Into Healthcare
Explore how artificial intelligence is expanding across healthcare, from clinical research and laboratory operations to patient care and commercial decision-making.
AI Is Reshaping the Future of Drug Discovery
See how AI is accelerating target identification, molecule design, clinical research, and the development of new medicines.
Claude Is Making Its Way Into Drug Discovery
Learn how Claude and other advanced AI models are being applied to pharmaceutical research, scientific analysis, and the drug discovery process.
Eli Lilly's Next-Generation Obesity Drug Shows Up to 28% Weight Loss
Eli Lilly’s next-generation obesity treatment delivered weight loss of up to 28%, highlighting the rapidly intensifying competition in the GLP-1 market.
Eli Lilly's Next-Generation Obesity Drug Shows Up to 28% Weight Loss
A second look at Eli Lilly’s next-generation obesity drug, its reported weight-loss results, and what the findings could mean for the future obesity-treatment market.
Google-Backed AI Startup Raises $2.1 Billion for Drug Discovery
Explore how a Google-backed AI startup raised $2.1 billion to expand AI-powered drug discovery and accelerate the development of new medicines.
The $64 Billion Shift in U.S. Drug Pricing
Understand the $64 billion shift reshaping U.S. drug pricing, reimbursement, access, and the commercial strategies of pharmaceutical companies.